Clinical Trial Update: Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study [Phase 3]

View source ↗

Summary

This document reports the completion and results posting for a Phase 3 follow-up trial in rheumatoid arthritis patients with moderate to low disease activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-10-31